IsisCB Explore

Article ID: CBB362630000

Disease-mongering through clinical trials (2015)

González-Moreno, María (Author)
Saborido, Cristian (Author)
Teira, David (Author)

Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences
Volume: 51
Pages: 11-18

URI: https://www.sciencedirect.com/science/article/pii/S1369848615000382

DOI: 10.1016/j.shpsc.2015.02.007

Outside Links

WorldCat

Google Scholar

JSTOR

Academia.edu

Pharmacy Methodology of science; scientific method Philosophy of science Statistical methods Clinical trials Disease and diseases Marketing techniques Pharmaceutical industry Medicalization 21st century 20th century

Our goal in this paper is to articulate a precise concept of at least a certain kind of disease-mongering, showing how pharmaceutical marketing can commercially exploit certain diseases when their best definition is given through the success of a treatment in a clinical trial. We distinguish two types of disease-mongering according to the way they exploit the definition of the trial population for marketing purposes. We argue that behind these two forms of disease-mongering there are two well-known problems in the statistical methodology of clinical trials (the reference class problem and the distinction between statistical and clinical significance). Overcoming them is far from simple.

...More

Citation URI

https://data.isiscb.org/isis/citation/CBB362630000/

Citations Indexes

Similar Citations

Thesis Greene, Jeremy Alan; (2005)
The Therapeutic Transition: Pharmaceuticals and the Marketing of Chronic Disease (/isis/citation/CBB001561804/)

Book Fisher, Jill; (2009)
Medical Research for Hire: The Political Economy of Pharmaceutical Clinical Trials (/isis/citation/CBB000953570/)

Article Giulia Bovone; (2020)
Bioplastina Serono: il ricostituente preferito dagli italiani (XX secolo) (/isis/citation/CBB350646575/)

Book Quirke, Viviane; Slinn, Judy; (2009)
Perspectives on Twentieth-Century Pharmaceuticals (/isis/citation/CBB001022688/)

Article Enrico Cevolani; (2020)
Dai cerotti Plastod all’Idrobitume: le invenzioni di Umberto Dotta, chimico e farmacista bolognese (/isis/citation/CBB399905160/)

Book Clarke, Adele E.; Mamo, Laura; Fosket, Jennifer Ruth; (2010)
Biomedicalization: Technoscience, Health, and Illness in the U.S. (/isis/citation/CBB001023175/)

Essay Review Strasser, Bruno J.; (2008)
Magic Bullets and Wonder Pills: Making Drugs and Diseases in the Twentieth (/isis/citation/CBB001566270/)

Article Ilenia Garoia; (2017)
Farmacista, preparatore, comunicatore, innovatore: il caso Oreste Ruggeri (1857-1912) (/isis/citation/CBB233428609/)

Thesis Fisher, Jill A.; (2005)
Pharmaceutical Paternalism and the Privatization of Clinical Trials (/isis/citation/CBB001561585/)

Article Alessandro Demichelis; (2018)
Understanding vaccine hesitancy: Cognitive biases and the role of trust (/isis/citation/CBB568141355/)

Article Enrico Cevolani; (2016)
Un futuro per la canapa? Dall'alimentazione all'industria, il potenziale trascurato di una pianta straordinaria (/isis/citation/CBB591727814/)

Book Maki Umemura; (2011)
The Japanese Pharmaceutical Industry: Its Evolution and Current Challenges (/isis/citation/CBB223408454/)

Article Anna Greenwood; Hilary Ingram; (2018)
‘The People’s Chemists’: The Walgreens Boots Alliance Archive (/isis/citation/CBB146301261/)

Article Giulia Bovone; (2017)
L’opoterapia all'italiana attraverso i suoi prodotti: dalla lotta per l’emersione fino all'inesorabile declino (/isis/citation/CBB921489740/)

Article Paulina Oszajca; (2023)
Amore mortale. La storia dell’uso del radio nei prodotti di bellezza (/isis/citation/CBB453209942/)

Book Greene, Jeremy A.; Watkins, Elizabeth Siegel; (2012)
Prescribed: Writing, Filling, Using, and Abusing the Prescription in Modern America (/isis/citation/CBB001214574/)

Article Nicola Bertoldi; (2022)
“Batesonian Mendelism” and “Pearsonian biometry”: Shedding new light on the controversy between William Bateson and Karl Pearson (/isis/citation/CBB173602193/)

Article Giulia Bovone; (2019)
L’Arsenico: da strumento di morte ad antitumorale (XIX – XX - XXI secolo) (/isis/citation/CBB158105733/)

Article Jeremy A. Greene; (2017)
Therapeutic Proofs and Medical Truths: The Enduring Legacy of Early Modern Drug Trials (/isis/citation/CBB978757359/)

Multimedia Object Zoë Bossiere; Sarah Fawn Montgomery; (2020)
Sarah Fawn Montgomery, “Quite Mad: An American Pharma Memoir” (Mad Creek Books, 2018) (/isis/citation/CBB148363336/)

Comments

{{ comment.created_by.username }} on {{ comment.created_on | date:'medium' }}